Abivax SA (ABVX)

113.35 -0.95 (-0.83%) USD  |  NASDAQ  |  Aug 28, 16:00
113.39 +0.04 (+0.04%) After-Hours: 20:00
More

Abivax Total Expenses (Quarterly)

Total Expenses (Quarterly) Chart

View Total Expenses (Quarterly) for ABVX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (Quarterly) Chart
Start Trial

Historical Total Expenses (Quarterly) Data

View and export this data back to 2025. Start Trial.
Date Value
March 31, 2026 --
December 31, 2025 --
September 30, 2025 --
Date Value
June 30, 2025 --
March 31, 2025 --

Total Expenses (Quarterly) Range, Past 5 Years

View Total Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Quarterly) Benchmarks

View Total Expenses (Quarterly) Benchmarks
Start Trial
Poxel SA --
OSE Immunotherapeutics SA --
Cogent Biosciences, Inc. Upgrade
Compass Pathways Plc Upgrade
Vera Therapeutics, Inc. Upgrade

Total Expenses (Quarterly) Related Metrics

Net Income (Quarterly) Upgrade
EPS Diluted (Quarterly) Upgrade
Enterprise Value Upgrade
Earnings Yield Upgrade
Normalized Earnings Yield Upgrade